Limited predictive value of cardiopulmonary exercise indices in patients with moderate chronic heart failure treated with carvedilol

American Heart Journal

Volumn 147, Issue 3, 2004, Pages 553-560

  Corrà, Ugo ^a   Mezzani, Alessandro ^a   Bosimini, Enzo ^a   Scapellato, Francesco ^a   Temporelli, Pier Luigi ^a   Eleuteri, Ermanno ^a   Giannuzzi, Pantaleo ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CARVEDILOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYNAMIC EXERCISE; EMERGENCY SURGERY; EXERCISE TEST; FEMALE; GAS EXCHANGE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; CONGESTIVE HEART FAILURE; HEART STROKE VOLUME; LUNG GAS EXCHANGE; METABOLISM; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; PROPANOLAMINES; PROPORTIONAL HAZARDS MODELS; PULMONARY GAS EXCHANGE; RISK FACTORS; STROKE VOLUME;

EID: 2342431159     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.10.026     Document Type: Article

References (21)

1. Roden D.M. Cardiovascular news Cardiovascular and Renal Advisory Panel of the US Food and Drug Administration consider four drugs. Circulation. 95:1997;2335-2337
2. Bello D., Shah N.B., Edep M.E., et al. Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure. Am Heart J. 138:1999;100-107
3. Maggioni A.P., Lucci D., Gorini M., et al. ACE-inhibitors utilization in congestive heart failure a survey on 2343 Italian outpatients. J Am Coll Cardiol. 29:1997;324-325a
4. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786
5. Costanzo M.R., Augustine S., Bourge R., et al. Selection and treatment of candidates for heart transplantation. Circulation. 92:1995;3595-3612
6. Corrà U., Mezzani A., Bosimini E., et al. Ventilatory response to exercise improves risk stratification in chronic heart failure patients with intermediate functional capacity. Am Heart J. 143:2002;418-426
7. Wasserman K., Hansen J.E., Sue D.Y., et al. Principles of exercise testing and interpretation. 1986;73 Lea & Febiger, Philadelphia
8. Beaver W.L., Wasserman K., Whipps B.J. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 60:1986;2020-2027
9. Giannuzzi P., Imparato A., Temporelli P.L., et al. Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 23:1994;1630-1637
10. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36
11. Brophy J.M., Joseph L., Rouleau J.L. β-Blockers in congestive heart failure a Bayesian Meta-analysis. Ann Intern Med. 134:2001;550-560
12. Bellotti P., Badano L.P., Acquarone N., et al. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure the OSCUR study. Eur Heart J. 22:2001;596-604
13. Kao W., Winkle E.M., Johnson M.R., et al. Role of maximal oxygen consumption in establishment of heart transplantation candidacy for heart failure patients with intermediate exercise tolerance. Am J Cardiol. 79:1997;1124-1127
14. Opasich C., Pinna G.D., Bobbio M., et al. Peak oxygen consumption in chronic heart failure toward efficient use in the individual patient. J Am Coll Cardiol. 31:1998;766-775
15. Myers J., Gullestad L., Vagelos R., et al. Cardiopulmonary exercise testing and prognosis in severe heart failure 14 mL/kg/min revisited. Am Heart J. 139:2000;78-84
16. Chua T.P., Ponikowski P., Harrington D., et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in CHF. J. Am Coll Cardiol. 29:1997;1585-1590
17. Zugck C., Haunnstetter A., Krüger C., et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol. 39:2002;1615-1622
18. Van Baak M.A. β-adrenoceptor blockade and exercise an update. Sports Med. 4:1988;209-225
19. Gullestad L., Hallen J., Medbo J.I., et al. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women. Br J Pharmacol. 41:1996;57-67
20. Mancini DM. Pulmonary factors limiting exercise capacity in patients with heart failure: Prog Cardiovasc Dis. 56:1995;347-370
21. Ponikwoski P., Chua T.P., Piepoli M., et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation. 96:1997;2586-2594